Remove 2025 Remove Plaque Remove Risk Factors
article thumbnail

Recurrent polymorphic ventricular tachycardia without chest pain: an unusual presentation of focal coronary artery spasm

The British Journal of Cardiology

This case report describes an atypical presentation of CAS in a 68-year-old white British male with cardiovascular risk factors. This case emphasises the importance of recognising plaque-associated CAS as a potential trigger for life-threatening arrhythmias, even in the absence of chest pain.

article thumbnail

Roche's Lp(a) Gen.2 Molarity Assay Receives FDA Clearance

DAIC

tim.hodson Mon, 02/03/2025 - 12:30 January 29, 2025 Roche announced today that the Tina-quant Lipoprotein (a) Gen.2 2 Molarity assay has received 510(k) clearance from the United States Food and Drug Administration (FDA). This will be the first 510(k) cleared test of its kind available in the U.S.

article thumbnail

Abstract WP338: Proteomic Analysis of Carotid Artery Plaques With and Without Vulnerable Features on Magnetic Resonance Angiography with Vessel Wall Imaging: A Pilot Study

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page AWP338-AWP338, February 1, 2025. Advancements in magnetic resonance angiography (MRA) with vessel wall imaging (VWI) have enabled the identification of vulnerable plaques, aiding in risk stratification for neurovascular events. Eleven plaques were vulnerable in preoperative MRI with VWI.

Plaque 40
article thumbnail

Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and Prospects

Circulation

Circulation, Volume 151, Issue 6 , Page 400-415, February 11, 2025. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk factor for astherosclerotic cardiovascular disease, with proinflammatory and prothrombotic mechanisms contributing to its atherogenicity.

article thumbnail

Abstract TP205: Alzheimer’s Disease and Risk of Intracranial Hemorrhage

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page ATP205-ATP205, February 1, 2025. Introduction:Alzheimers Disease (AD), characterized by extracellular deposition of amyloid beta (A) plaques in brain tissue, is often comorbid with cerebral amyloid angiopathy, which carries an elevated risk of intracranial hemorrhage.

article thumbnail

Abstract TP258: The Rapid Occluded Vessel Etiology Score: A Novel Algorithm to Identify Acute Atherosclerotic Large Vessel Occlusions of the Middle Cerebral Artery

Stroke Journal

Stroke, Volume 56, Issue Suppl_1 , Page ATP258-ATP258, February 1, 2025. Stroke risk factors and CT angiography (CTA) of the head and neck features were compared between LAA and non-LAA etiologies in a univariate analysis. p<0.0001), and ICA bulb plaque with high-risk features (87.9%

article thumbnail

Trial Results: Low-Dose Colchicine HelpsTreat Cardiovascular Disease

DAIC

tim.hodson Mon, 03/31/2025 - 10:26 March 31, 2025 AGEPHA Pharma USA, LLC, has released clinical data that provides new information about how low-dose colchicine, 0.5 mg reduces the risk of major adverse cardiovascular events (MACE) and supports its use in the treatment of cardiovascular disease. mg on atherosclerotic plaque.